tiprankstipranks
Molecular Templates Inc (MTEM)
NASDAQ:MTEM
US Market

Molecular Templates (MTEM) Stock Price & Analysis

509 Followers

MTEM Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$1.01 - $9.46
Previous Close$1.39
Volume62.71K
Average Volume (3M)45.59K
Market Cap
$9.15M
Enterprise Value$7.39M
Total Cash (Recent Filing)$11.50M
Total Debt (Recent Filing)$9.74M
Price to Earnings (P/E)
Beta0.85
Aug 08, 2024
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.36
Shares Outstanding6,583,880
10 Day Avg. Volume51,985
30 Day Avg. Volume45,591
Standard Deviation0.22
R-Squared0.08
Alpha-0.06
Financial Highlights & Ratios
Price to Book (P/B)1.70
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.11
Enterprise Value/Gross Profit0.14
Enterprise Value/Ebitda-6.99
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Website Traffic

Sorry, No Data Available
There is no website visitor data available for this stock.
---

MTEM FAQ

What was Molecular Templates Inc’s price range in the past 12 months?
Molecular Templates Inc lowest stock price was $1.01 and its highest was $9.46 in the past 12 months.
    What is Molecular Templates Inc’s market cap?
    Currently, no data Available
    When is Molecular Templates Inc’s upcoming earnings report date?
    Molecular Templates Inc’s upcoming earnings report date is Aug 08, 2024 which is in 20 days.
      How were Molecular Templates Inc’s earnings last quarter?
      Molecular Templates Inc released its earnings results on May 15, 2024. The company reported $0.08 earnings per share for the quarter, beating the consensus estimate of -$0.78 by $0.86.
        Is Molecular Templates Inc overvalued?
        According to Wall Street analysts Molecular Templates Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Molecular Templates Inc pay dividends?
          Molecular Templates Inc does not currently pay dividends.
          What is Molecular Templates Inc’s EPS estimate?
          Molecular Templates Inc’s EPS estimate is -$1.44.
            How many shares outstanding does Molecular Templates Inc have?
            Molecular Templates Inc has 6,583,880 shares outstanding.
              What happened to Molecular Templates Inc’s price movement after its last earnings report?
              Molecular Templates Inc reported an EPS of $0.08 in its last earnings report, beating expectations of -$0.78. Following the earnings report the stock price went up 3.448%.
                Which hedge fund is a major shareholder of Molecular Templates Inc?
                Among the largest hedge funds holding Molecular Templates Inc’s share is Woodline Partners LP. It holds Molecular Templates Inc’s shares valued at N/A.
                  ---

                  Molecular Templates Stock Smart Score

                  10
                  Unlock Smart Score
                  1
                  2
                  3
                  4
                  5
                  6
                  7
                  8
                  9
                  10

                  Technicals

                  SMA
                  Negative
                  20 days / 200 days
                  Momentum
                  -83.10%
                  12-Months-Change

                  Fundamentals

                  Return on Equity
                  -929.14%
                  Trailing 12-Months
                  Asset Growth
                  -65.46%
                  Trailing 12-Months

                  Company Description

                  Molecular Templates Inc

                  Molecular Templates, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of biologic therapeutics for the treatment of cancers and other serious diseases. The company utilizes its proprietary biologic drug platform to design and generate engineered toxin bodies, or ETBs. Molecular Templates was founded on October 17, 2001 and is headquartered in Austin, TX.
                  ---
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  RAPT Therapeutics
                  Crinetics Pharmaceuticals
                  Adaptimmune Therapeutics
                  Cytokinetics
                  Popular Stocks
                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis